Get the Stockscreener App
52.25
2.23%
1.09
State Street Spdr S P Pharmaceuticals Etf stock is traded at $52.25, with a volume of 17,026.
It is up +2.23% in the last 24 hours and up +6.67% over the past month.
See More
Previous Close:
$51.16
Open:
$51.23
24h Volume:
17,026
Relative Volume:
0.28
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.03%
1M Performance:
+6.67%
6M Performance:
+31.41%
1Y Performance:
+12.86%
1-Day Range:
$51.20
$52.41
1-Week Range:
$50.95
$52.83
52-Week Range:
$35.22
$52.83
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Name
State Street Spdr S P Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
52.25 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
324.19 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
659.99 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
663.29 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
247.47 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
590.89 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Latest News
LVLNState Street SPDR S&P Leveraged Loan ETF Stock Price and Quote - Finviz
S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily
Why biotech and drug stocks are rallying even though the rest of the market is hurting - MarketWatch
Is State Street SPDR S&P Aerospace & Defense ETF (XAR) a Strong ETF Right Now? - Yahoo Finance
XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component - Seeking Alpha
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results - sharewise.com
SLYV: Unconvincing Small Cap ETF (NYSEARCA:SLYV) - Seeking Alpha
META_TITLE_SECTORS - Yahoo Finance
SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'CVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Should You Invest in the State Street SPDR S&P Semiconductor ETF (XSD)? - Yahoo Finance
XOP: Exploring The Structure And Suitability Of This Energy ETF - Seeking Alpha
Should You Invest in the State Street SPDR S&P Oil & Gas Exploration & Production ETF (XOP)? - Yahoo Finance
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
State Street Renames Dozens of ETFs Ahead of 401(k) Play - Yahoo Finance
Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Bank ETF (KBE) a Strong ETF Right Now? - Yahoo Finance
2 Classic ETFs Were Back in Favor in October - ETF Trends
Biopharmaceutical stocks performed strongly against the market trend, bolstered by industry mergers and acquisitions as well as favorable policy developments. - 富途牛牛
5 Best Medical Device Stocks for 2025 - The Motley Fool
Why Is Intellia Therapeutics Stock Sinking Monday?Intellia Therapeutics (NASDAQ:NTLA) - Benzinga
P Pharmaceuticals ETF stock responds to job market shiftsWeekly Trade Analysis & Fast Moving Stock Trade Plans - newser.com
Aug Analyst Calls: P Pharmaceuticals ETF stock enhance shareholder valueMarket Movers & Daily Chart Pattern Signals - nchmf.gov.vn
P Pharmaceuticals ETF stock enhance shareholder value2025 Earnings Impact & Real-Time Volume Surge Alerts - newser.com
P Pharmaceuticals ETF stock prepared for digital transition2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
P Pharmaceuticals ETF stock overpriced at current multiples2025 Retail Activity & Daily Chart Pattern Signal Reports - Trung tâm Dự báo KTTV quốc gia
P Pharmaceuticals ETF stock return to pre crash levelsProduct Launch & Daily Risk Controlled Trade Plans - Trung tâm Dự báo KTTV quốc gia
SPDR Series TrustSPDR S&P Pharmaceuticals ETF (SSGE.HM) latest stock news and headlines - Yahoo
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView
SPDR S&P Semiconductor ETF (XSD) stock price, news, quote and history - Yahoo Finance UK
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures - Benzinga
XPH: Small-Cap Pharma Turns Higher, At Long Last (NYSEARCA:XPH) - Seeking Alpha
Seeking Alpha's healthcare quant picks ahead of Q3 earnings: McKesson, Incyte top-rated stocks - MSN
Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock - MSN
P Pharmaceuticals ETF stock beat international competitionJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
SPDR Pharmaceuticals ETF Index (^KZP) options chain - Yahoo
P Pharmaceuticals ETF stock protected from inflationJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
If You Invested in SPDR S&P 500 ETF (SPY) 5 Years Ago, You Would Be Up 89.72% Today - 24/7 Wall St.
The S&P 500 ETF wars are over — VOO has won out over SPY - Sherwood News
Should SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar? - Yahoo Finance
State Street's flagship S&P 500 ETF recorded an outflow of $32.7 billion, marking the largest scale in its history. - 富途牛牛
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline - Benzinga
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
3 Reasons To Be Optimistic Around Biotech In Q4 - Seeking Alpha
INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag - MSN
The Best Biotech ETFs to Buy - Kiplinger
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman - Seeking Alpha
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
Should SPDR S&P 400 Mid Cap Growth ETF (MDYG) Be on Your Investing Radar? - Yahoo Finance
6 Best Health Care Funds and ETFs for 2025 - US News Money
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for State Street Spdr S P Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):